(S)-3-(4-Acetoxyphenyl)-2-aminopropanoic acid, 95.0%, 1g

4'-Iodo-[1,1'-biphenyl]-4-ol, 95+%, 5g

1-[(4-Fluorophenyl)methyl]cyclopropane-1-carboxylic acid, 250mg

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4-Chloro-2-methyl-6-trifluoromethylpyrimidine, 95.0%, 10g

3-Methoxycinnamic Acid>99.0%(GC)(T)250g

CITRONELLAL, 96%, 25g

L-O-Phosphoserine>98.0%(T)5g

4-hydroxyoxane-4-carboxylic acid, 95.0%, 250mg

6-Methylpyridazin-3-amine, 97.0%, 10g

Imidazo[1,2-a]pyridine-6-boronic acid, 95.0%, 5g

Ethyl 6-chloro-3,4-dimethylthieno[2,3-b]pyridine-2-carboxylate, 98%, 250mg

Phase contrast slide set with 20x and S100x PLPHi IOS infinity corrected objectives and phase contrast rings for 20x/S100x